Year |
Citation |
Score |
2020 |
Alcalay RN, Wolf P, Chiang MSR, Helesicova K, Zhang XK, Merchant K, Hutten SJ, Scherzer C, Caspell-Garcia C, Blauwendraat C, Foroud T, Nudelman K, Gan-Or Z, Simuni T, Chahine LM, ... Levy O, et al. Longitudinal Measurements of Glucocerebrosidase activity in Parkinson's patients. Annals of Clinical and Translational Neurology. PMID 32888397 DOI: 10.1002/Acn3.51164 |
0.301 |
|
2019 |
Kovalchuke L, Mosharov EV, Levy OA, Greene LA. Stress-induced phospho-ubiquitin formation causes parkin degradation. Scientific Reports. 9: 11682. PMID 31406131 DOI: 10.1038/s41598-019-47952-5 |
0.304 |
|
2018 |
Park S, Burke RE, Kareva T, Kholodilov N, Aimé P, Franke TF, Levy O, Greene LA. Context-dependent expression of a conditionally-inducible form of active Akt. Plos One. 13: e0197899. PMID 29920520 DOI: 10.1371/journal.pone.0197899 |
0.317 |
|
2018 |
Sun X, Aimé P, Dai D, Ramalingam N, Crary JF, Burke RE, Greene LA, Levy OA. Guanabenz promotes neuronal survival via enhancement of ATF4 and parkin expression in models of Parkinson disease. Experimental Neurology. PMID 29432724 DOI: 10.1016/J.Expneurol.2018.01.015 |
0.392 |
|
2015 |
Aimé P, Sun X, Zareen N, Rao A, Berman Z, Volpicelli-Daley L, Bernd P, Crary JF, Levy OA, Greene LA. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 10731-49. PMID 26224857 DOI: 10.1523/Jneurosci.0614-15.2015 |
0.417 |
|
2014 |
Romaní-Aumedes J, Canal M, Martín-Flores N, Sun X, Pérez-Fernández V, Wewering S, Fernández-Santiago R, Ezquerra M, Pont-Sunyer C, Lafuente A, Alberch J, Luebbert H, Tolosa E, Levy OA, Greene LA, et al. Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson's disease. Cell Death & Disease. 5: e1364. PMID 25101677 DOI: 10.1038/Cddis.2014.333 |
0.356 |
|
2013 |
Sun X, Liu J, Crary JF, Malagelada C, Sulzer D, Greene LA, Levy OA. ATF4 protects against neuronal death in cellular Parkinson's disease models by maintaining levels of parkin. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 2398-407. PMID 23392669 DOI: 10.1523/Jneurosci.2292-12.2013 |
0.41 |
|
2011 |
Greene LA, Levy O, Malagelada C. Akt as a victim, villain and potential hero in Parkinson's disease pathophysiology and treatment. Cellular and Molecular Neurobiology. 31: 969-78. PMID 21547489 DOI: 10.1007/s10571-011-9671-8 |
0.354 |
|
2009 |
Levy OA, Malagelada C, Greene LA. Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps. Apoptosis : An International Journal On Programmed Cell Death. 14: 478-500. PMID 19165601 DOI: 10.1007/s10495-008-0309-3 |
0.38 |
|
2002 |
Levy OA, Lah JJ, Levey AI. Notch signaling inhibits PC12 cell neurite outgrowth via RBP-J-dependent and -independent mechanisms. Developmental Neuroscience. 24: 79-88. PMID 12145413 DOI: 10.1159/000064948 |
0.4 |
|
2001 |
Killick R, Pollard CC, Asuni AA, Mudher AK, Richardson JC, Rupniak HT, Sheppard PW, Varndell IM, Brion JP, Levey AI, Levy OA, Vestling M, Cowburn R, Lovestone S, Anderton BH. Presenilin 1 independently regulates beta-catenin stability and transcriptional activity. The Journal of Biological Chemistry. 276: 48554-61. PMID 11606587 DOI: 10.1074/Jbc.M108332200 |
0.317 |
|
Show low-probability matches. |